David Moadel
All articles

Everything by David.

1,329 articles

← Back to profile
Investing

BofA Doubles Down on Alphabet at $430 Price Target After I/O 2026 AI Showcase

May 20, 2026
Investing

UnitedHealth Price Target Lifted to $440 at Mizuho: The Managed Care Storm Clouds Are Clearing

May 20, 2026
Investing

Wells Fargo Trims Meta Platforms Price Target to $765: Why the AI Infrastructure Bet Still Has Believers

May 20, 2026
Investing

Stifel Just Crowned CrowdStrike With a $660 Price Target. The Bull Case Just Got Louder

May 20, 2026
Investing

Home Depot Price Targets Slashed Across Wall Street After Q1: Has the Home Improvement Slowdown Just Begun?

May 20, 2026
Investing

Marvell Price Target Vaults to $195 at Wells Fargo on AWS Trainium and Custom Silicon Momentum

May 20, 2026
Investing

Susquehanna Raises Baidu Price Target to $140 on AI Cloud Surge. Why Still Neutral?

May 20, 2026
Investing

Humana Just Got a Massive Upgrade From Deutsche Bank: Price Target Nearly Doubles to $441

May 20, 2026
Investing

Goldman Sachs Lifts Enphase Price Target to $57: Is the Residential Solar Trade Back On?

May 20, 2026
Investing

Super Micro Computer Is Up 7% Today: Is It Outperforming Other AI Server Stocks Like Dell and Hewlett Packard Enterprise?

May 20, 2026
Investing

Target Is Melting Down Today. Should Walmart and Costco Stockholders Worry?

May 20, 2026
Investing

Intel Is Up 8% Today: Here’s Why

May 20, 2026
Investing

Arm Holdings Has Doubled in 2026. Is It Outperforming Other Chip-IP Stocks Like Synopsys, Cadence, and Qualcomm?

May 19, 2026
Investing

Pinterest Is Down 6% Today. Here’s Why It’s Trailing Other Social Media Stocks Like Meta Platforms and Snap

May 19, 2026
Investing

Micron Is Up 6% Today: Is It Outperforming Other Memory Stocks Like SanDisk and Western Digital?

May 19, 2026
Investing

Oklo Sinks 5%, Uranium Energy Tumbles 9%, Energy Fuels Slides 6%: The Nuclear Trade Goes Cold

May 19, 2026
Investing

X-Energy Lands 5 Buy Ratings From Wall Street: Guggenheim Sets Top Price Target at $57

May 19, 2026
Investing

Guggenheim Just Slapped a Buy Rating on StubHub. $12.50 Price Target Bets on the Live Events Boom

May 19, 2026
Investing

UBS Just Upgraded Jazz Pharma to Buy. New $307 Price Target Could Signal a Turning Point

May 19, 2026
Investing

BofA Just Reinstated Zeta as a Buy With a $24 Price Target. Is AdTech Heating Up?

May 19, 2026